We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRUS
3776
DELISTED
Merus
MRUS
$23K ﹤0.01%
+1,328
New +$19.6K
MSBI icon
3777
Midland States Bancorp
MSBI
$698M
$23K ﹤0.01%
1,277
-5,121
-80% -$83.5K
PASG icon
3778
Passage Bio
PASG
$14.7M
$23K ﹤0.01%
44
-575
-93% -$230K
PDEX icon
3779
Pro-Dex
PDEX
$217M
$23K ﹤0.01%
748
-1,875
-71% -$66.3K
PPSI
3780
Pioneer Power Solutions
PPSI
$33.5M
$23K ﹤0.01%
5,827
+2,314
+66% +$8.24K
RYTM icon
3781
Rhythm Pharmaceuticals
RYTM
$7.99B
$23K ﹤0.01%
784
-1,233
-61% -$31.3K
FLNA
3782
Filana Therapeutics
FLNA
$45.7M
$23K ﹤0.01%
3,407
-19,106
-85% -$171K
SMP icon
3783
Standard Motor Products
SMP
$870M
$23K ﹤0.01%
568
-14,693
-96% -$690K
SSYS icon
3784
Stratasys
SSYS
$779M
$23K ﹤0.01%
1,109
-6,064
-85% -$97.3K
VRDN icon
3785
Viridian Therapeutics
VRDN
$2.49B
$23K ﹤0.01%
1,392
+1,234
+781% +$18.6K
WRAP icon
3786
Wrap Technologies
WRAP
$97.4M
$23K ﹤0.01%
4,783
-7,294
-60% -$42.3K
XWEL icon
3787
XWELL
XWEL
$8.53M
$23K ﹤0.01%
+971
New +$34.2K
TARO
3788
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$23K ﹤0.01%
312
-77
-20% -$4.95K
ARAV
3789
DELISTED
Aravive, Inc. Common Stock
ARAV
$23K ﹤0.01%
4,058
-7,384
-65% -$40.5K
AUVI
3790
DELISTED
Applied UV, Inc. Common Stock
AUVI
$23K ﹤0.01%
+41
New +$29.7K
AXLA
3791
DELISTED
Axcella Health Inc. Common Stock
AXLA
$23K ﹤0.01%
184
-291
-61% -$37.4K
SHLX
3792
DELISTED
Shell Midstream Partners, L.P.
SHLX
$23K ﹤0.01%
2,312
-5,657
-71% -$55.2K
TSC
3793
DELISTED
TriState Capital Holdings, Inc.
TSC
$23K ﹤0.01%
1,328
-3,076
-70% -$46.3K
GWGH
3794
DELISTED
GWG Holdings, Inc
GWGH
$23K ﹤0.01%
3,248
-541
-14% -$4.28K
BFT
3795
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
$23K ﹤0.01%
+1,500
New +$17.1K
CZZ
3796
DELISTED
Cosan Limited
CZZ
$23K ﹤0.01%
1,280
-3,374
-72% -$56.3K
ABEV icon
3797
Ambev
ABEV
$43.8B
$22K ﹤0.01%
7,252
-11,431
-61% -$30.8K
BFST icon
3798
Business First Bancshares
BFST
$1.05B
$22K ﹤0.01%
1,087
-12,620
-92% -$233K
CLIR icon
3799
ClearSign Technologies
CLIR
$28.9M
$22K ﹤0.01%
+752
New +$19.6K
CVE icon
3800
Cenovus Energy
CVE
$56.4B
$22K ﹤0.01%
3,649
-32,748
-90% -$153K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.